1Q EARNINGS: Lilly sales sink as growth floats to 2015
This article was originally published in Scrip
Executive Summary
Eli Lilly didn't goose its latest earnings report or quack about successes outside of commercial activities to divert attention from the company's expected sales slump, but Lilly is getting its research and business development ducks in a row to ensure growth in 2015.